Early metformin in gestational diabetes: a randomized clinical trial
Dunne F, Newman C, Alvarez-Iglesias A, et al.
JAMA. 2023 Oct 3:e2319869.
Leggi
Breaking news
Antihypertensive and lipid-lowering medication adherence in young adults with youth-onset type 2 diabetes
Weinstock RS, Trief PM, Burke BK, et al.
JAMA Netw Open. 2023;6(10):e2336964.
Leggi
Association between timing and consistency of physical activity and type 2 diabetes: a cohort study on participants of the UK Biobank
Tian C, Bürki C, Westerman KE, Patel CJ
Diabetologia. Pub. online 20 Sep 2023.
Leggi
Long‐term effects of coronavirus disease 2019 on diabetes complications and mortality in people with diabetes: Two cohorts in the UK and Hong Kong
Wan EYF, Mathur S, Zhang R, et al.
Diabetes Obes Metab. Pub. online 21 Sep 2023.
Leggi
Mechanisms of weight loss-induced remission in people with prediabetes: a post-hoc analysis of the randomised, controlled, multicentre Prediabetes Lifestyle Intervention Study (PLIS)
Sandforth A, von Schwartzenberg RJ, Vazquez Arreola E, et al.
Lancet Diabetes Endocrinol. 2023;S2213-8587(23)00235-8.
Leggi
Risk of thyroid cancer associated with glucagon‐like peptide‐1 receptor agonists and dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes: A population‐based cohort study
Bea S, Son H, Bae JH, et al.
Diabetes Obes Metab. Pub. online 21 Sep 2023.
Leggi
Semaglutide in patients with heart failure with preserved ejection fraction and obesity
Kosiborod MN, Abildstrøm SZ, Borlaug BA, et al.
N Engl J Med. 2023;389(12):1069-1084.
Leggi
Impact of type 2 diabetes on the outcomes of solid organ transplantations in the U.S.: data from a national registry
Stepanova M, Kumar A, Brandt P, et al.
Diabetes Care. 2023;dc231085.
Leggi
The real‐world observational prospective study of health outcomes with dulaglutide and liraglutide in type 2 diabetes patients (TROPHIES): final patient‐reported outcomes at 24 months
Boye KS, Lebrec J, Dib A, et al.
Diabetes Obes Metab. Pub. online 15 Sep 2023.
Leggi
Comparative effectiveness of aspirin dosing in cardiovascular disease and diabetes mellitus: a subgroup analysis of the adaptable trial
Narcisse DI, Kim H, Wruck LM, et al.
Diabetes Care. 2023;dc230749.
Leggi